Syntrix Presents at the 2013 NHLBI Innovation Conference in San Francisco

Syntrix was one of six breakthrough technology companies invited to present at the 2013 Innovation Conference sponsored by the National Heart Lung and Blood Institute (NHLBI).  This conference brings together businesses, investors, and strategic partners from the biotech and pharmaceutical industries. It features presentations by top NHLBI-funded companies with innovative technologies.  The Syntrix presentation featured SX-682, the company’s game-changing new treatment for chronic obstructive pulmonary disease.

Read about SX-682 in our pipeline.

Watch the conference presentation by Dr. Dean Maeda.

The conference webpage.